HLA-C and neoplasm: Immune phenotype scoring revealed that the high-risk group had a lower MHC score, reflecting impaired antigen presentation capacity, which further suggests the presence of immune escape mechanisms that could undermine immune surveillance and anti-tumor immune responses.